The rapidly developing field of nuclear medicine tracers — or probes — to noninvasively study cancer cells in real time during treatment got an “exciting” boost this week. A research team from Massachusetts General Hospital in Boston and Memorial Sloan Kettering in New York City published findings in the Journal of Nuclear Medicine that may help doctors respond more accurately with supplemental cancer treatments.  {read more here}